Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies

MLA

Jorge Barriuso, et al. “Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies.” Clinical Cancer Research, vol. 17, May 2011, pp. 3420–30. EBSCOhost, https://doi.org/10.1158/1078-0432.ccr-10-2946.

APA

Jorge Barriuso, Sarah P. Blagden, Mohammed M. Dar, Andre T. Brunetto, Thomas A. Lampkin, Richard H. Wilson, David Olmos, Hanine Medani, Alicia Allred, Timothy A. Yap, Deborah A. Smith, Anne B. Taegtmeyer, Douglas Barker, Yan Degenhardt, Johann S. de Bono, Rohini Sharma, & Sharon C. Murray. (2011). Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies. Clinical Cancer Research, 17, 3420–3430. https://doi.org/10.1158/1078-0432.ccr-10-2946

Chicago

Jorge Barriuso, Sarah P. Blagden, Mohammed M. Dar, Andre T. Brunetto, Thomas A. Lampkin, Richard H. Wilson, David Olmos, et al. 2011. “Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies.” Clinical Cancer Research 17 (May): 3420–30. doi:10.1158/1078-0432.ccr-10-2946.